Royce & Associates’s LiqTech LIQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-72,515
Closed -$3.18M 999
2021
Q3
$3.18M Sell
72,515
-53,933
-43% -$2.53M 0.02% 671
2021
Q2
$7.41M Sell
126,448
-1,780
-1% -$108K 0.05% 514
2021
Q1
$8.3M Buy
128,228
+10,238
+9% +$770K 0.06% 488
2020
Q4
$7.55M Buy
117,990
+24,820
+27% +$1.55M 0.06% 458
2020
Q3
$6.3M Buy
93,170
+4,242
+5% +$234K 0.07% 421
2020
Q2
$3.88M Buy
88,928
+25,376
+40% +$1.06M 0.04% 510
2020
Q1
$2.18M Buy
63,552
+35,200
+124% +$1.55M 0.03% 570
2019
Q4
$1.33M Buy
+28,352
New +$1.45M 0.01% 769

Other funds holding LIQT

Royce & Associates's LIQT Position: Q4 2021 in Review

Royce & Associates sold out of LiqTech (LIQT) in Q4 2021, closing a stake of 72,515 shares — an estimated $3.18M sold.

Royce & Associates first reported a position in LIQT in Q4 2019 and held it in 8 quarters. The position peaked at $8.3M in Q1 2021. 34 funds tracked by Wall St. Rank hold LIQT as of Q4 2021.

  • Royce & Associates reported no remaining LiqTech position as of Q4 2021 after selling out during the quarter.
  • Royce & Associates sold 72,515 LiqTech shares in Q4 2021, an estimated $3.18M.
  • Royce & Associates first reported a position in LiqTech in Q4 2019 and held it in 8 quarters.
  • Royce & Associates's LiqTech position peaked at $8.3M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held LiqTech as of Q4 2021.

Based on Royce & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.